Intrinsiqs

Is Pacira BioSciences, Inc. overvalued?

Pacira BioSciences, Inc. (PCRX) looks undervalued — trading about 166% below its fair value.

Undervalued
Current price $36.46 Fair value $97.02
Price
$36.46
Fair value
$97.02
Current P/E
14.0
Normal P/E
37.2
Market cap
$1.46B
Dividend yield
0.0%
Return on equity
5.5%
Sector
Healthcare

See the full interactive analysis →

Fair value compares PCRX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.